½ÃÀ庸°í¼­
»óǰÄÚµå
1529686

±â°üÀý°³ Æ©ºê ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : À¯Çüº°, Àα¸Åë°èº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2030³â)

Tracheostomy Tubes Market Size, Share & Trends Analysis Report By Type (Cuffed, Uncuffed), By Demographics (Adult Patients, Pediatric/Neonatal Patients), By End-use (Hospitals, Specialty Clinics), By Region, And Segment Forecasts, 2024 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 130 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

±â°üÀý°³ Æ©ºê ½ÃÀå ¼ºÀå°ú µ¿Çâ:

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¼¼°è ±â°ü Àý°³ Æ©ºê ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 1¾ï 3,670¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2024³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 4.2%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ ½ÃÀåÀº ¸¸¼º È£Èí±â ÁúȯÀÇ À¯º´·ü Áõ°¡, ±â¼ú ¹ßÀü, ¿Ü°ú ¼ö¼úÀÇ Áõ°¡·Î ÀÎÇØ Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ³ëÀÎÀº ±â°üÀý°³¼úÀÌ ÇÊ¿äÇÑ È£Èí±â Áúȯ¿¡ °É¸®±â ½±±â ¶§¹®¿¡ °í·ÉÈ­°¡ ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 8¿ù¿¡ ¹ßÇ¥µÈ ¹Ì±¹ ±¹¸³»ý¹°°øÇÐÁ¤º¸¼¾ÅÍ(NCBI)ÀÇ µ¥ÀÌÅÍ¿¡ µû¸£¸é ¹Ì±¹ÀεéÀº º¸Åë ÀÏ»ý µ¿¾È ¾à 9¹øÀÇ ¼ö¼úÀ» ¹Þ½À´Ï´Ù. ¹Ì±¹¿¡¼­´Â ¸Å³â 5,100¸¸ °Ç ÀÌ»óÀÇ ¼ö¼úÀÌ ÀÌ·ç¾îÁö°í ÀÖÀ¸¸ç, ³ëÀÎÀÌ ¼ö¼ú ȯÀÚ ¼öÀÇ °ÅÀÇ Àý¹ÝÀ» Â÷ÁöÇÕ´Ï´Ù.

º¸°ÇÀÇ·á ÀÎÇÁ¶ó°¡ °­È­µÇ°í, À¯¸®ÇÑ »óȯ Á¤Ã¥ÀÌ ½ÃÇàµÇ¸é¼­ Àü ¼¼°èÀûÀ¸·Î ±â°üÀý°³¼ú¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ±â°üÀý°³¼ú¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í Àü¹® ±³À°ÀÌ È®´ëµÇ¸é¼­ º¸±Þ·üÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ³ôÀº ºñ¿ë°ú ÀáÀçÀûÀÎ ÇÕº´Áõ µîÀÇ ¹®Á¦¿¡µµ ºÒ±¸Çϰí, Áö¼ÓÀûÀÎ ±â¼ú Çõ½Å°ú ȯÀÚ °á°ú °³¼±¿¡ ÈûÀÔ¾î ½ÃÀåÀº °è¼Ó È®´ëµÇ°í ÀÖ½À´Ï´Ù.

±â°üÀý°³ Æ©ºê ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • À¯Çüº°·Î´Â Ä¿ÇÁ½º ºÎ¹®ÀÌ 2023³â 62.7%ÀÇ °¡Àå Å« ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇßÀ¸¸ç, ¿¹Ãø ±â°£ µ¿¾È 4.3%ÀÇ CAGR·Î °¡Àå ºü¸£°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • Àα¸ Åë°èÇп¡ µû¸£¸é, ¼ºÀΠȯÀÚ ºÎ¹®Àº 2023³â 71.8%·Î °¡Àå Å« ¸ÅÃâ ºñÁßÀ» Â÷ÁöÇßÀ¸¸ç, ¿¹Ãø ±â°£ µ¿¾È 4.4%ÀÇ CAGR·Î °¡Àå ºü¸£°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • ÃÖÁ¾ ¿ëµµ¿¡ µû¶ó º´¿ø ºÎ¹®Àº 2023³â 49.4%·Î °¡Àå Å« ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇßÀ¸¸ç, ±â°üÀý°³¼úÀÇ ´ëºÎºÐÀ» Â÷ÁöÇϰí ÀÌ·¯ÇÑ ÀåÄ¡°¡ ÇÊ¿äÇÑ È¯ÀÚ¿¡°Ô Àü¹®ÀûÀÎ Ä¡·á¿Í °ü¸®¸¦ Á¦°øÇϱ⠶§¹®¿¡ ¿¹Ãø ±â°£ µ¿¾È 4.7%ÀÇ °¡Àå ºü¸¥ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • 2023³â¿¡´Â ºÏ¹Ì°¡ 36.7%ÀÇ Á¡À¯À²·Î ¿ìÀ§¸¦ Â÷ÁöÇß½À´Ï´Ù.ÀÌ Áö¿ªÀº ³ôÀº ¼öÁØÀÇ ÀÇ·á ÀÎÇÁ¶ó, ³ôÀº È£Èí±â Áúȯ À¯º´·ü, ³ôÀº ÀÇ·áºñ ÁöÃâ·Î ÀÎÇØ ÁÖµµÇϰí Àֱ⠶§¹®ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ±â°üÀý°³ Æ©ºê ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
    • »óºÎ ½ÃÀå Àü¸Á
    • °ü·Ã/ºÎ¼ö ½ÃÀå Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ±â°üÀý°³ Æ©ºê ½ÃÀå ºÐ¼® Åø
    • ¾÷°è ºÐ¼® - Porter's Five Forces ºÐ¼®
    • PESTEL ºÐ¼®

Á¦4Àå ±â°üÀý°³ Æ©ºê ½ÃÀå : À¯Çüº° ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ±â°üÀý°³ Æ©ºê ½ÃÀå : À¯Çüº° º¯µ¿ ºÐ¼®
  • ±â°üÀý°³ Æ©ºê ½ÃÀå : À¯Çüº° Àü¸Á
  • 2018³âºÎÅÍ 2030³â±îÁö ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®
  • ¼ö°©
  • ¼ö°© ¾øÀ½

Á¦5Àå ±â°üÀý°³ Æ©ºê ½ÃÀå : Àα¸Åë°èº° ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ±â°üÀý°³ Æ©ºê ½ÃÀå : Àα¸Åë°èº° º¯µ¿ ºÐ¼®
  • ±â°üÀý°³ Æ©ºê ½ÃÀå : Àα¸Åë°èº° Àü¸Á
  • 2018³âºÎÅÍ 2030³â±îÁö ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®
  • ¼ºÀΠȯÀÚ
  • ¼Ò¾Æ¡¤½Å»ý¾Æ ȯÀÚ

Á¦6Àå ±â°üÀý°³ Æ©ºê ½ÃÀå : ÃÖÁ¾ ¿ëµµº° ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ±â°üÀý°³ Æ©ºê ½ÃÀå : ÃÖÁ¾ ¿ëµµº° º¯µ¿ ºÐ¼®
  • ±â°üÀý°³ Æ©ºê ½ÃÀå : ÃÖÁ¾ ¿ëµµº° Àü¸Á
  • 2018³âºÎÅÍ 2030³â±îÁö ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®
  • º´¿ø
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • Àü¹® Ŭ¸®´Ð

Á¦7Àå ±â°üÀý°³ Æ©ºê ½ÃÀå : Áö¿ªº° ÃßÁ¤¡¤µ¿Ç⠺м®

  • Áö¿ª ´ë½Ãº¸µå
  • ±â°üÀý°³ Æ©ºê ½ÃÀå : Áö¿ªº° º¯µ¿ ºÐ¼®
  • ±â°üÀý°³ Æ©ºê ½ÃÀå : Áö¿ªº° ÃßÁ¤¡¤µ¿Ç⠺м®
  • 2018³âºÎÅÍ 2030³â±îÁö ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®
  • ºÏ¹Ì
    • ºÏ¹ÌÀÇ ±â°üÀý°³ Æ©ºê ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
    • À¯·´
    • À¯·´ÀÇ ±â°üÀý°³ Æ©ºê ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • µ§¸¶Å©
    • ½º¿þµ§
    • ³ë¸£¿þÀÌ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ±â°üÀý°³ Æ©ºê ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • ű¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ±â°üÀý°³ Æ©ºê ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ±â°üÀý°³ Æ©ºê ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • Äí¿þÀÌÆ®

Á¦8Àå °æÀï »óȲ

  • ½ÃÀå ÁøÃâ ±â¾÷ ºÐ·ù
  • ÁÖ¿ä ±â¾÷ °³¿ä
    • Pulmodyne, Inc.
    • Smiths Group plc
    • Medtronic
    • TRACOE Medical GmbH
    • Teleflex, Inc.
    • TuoRen
    • ConvaTec Group
    • Boston Medical
    • Fisher &Paykel Healthcare Ltd.
    • Angioplast
    • ICU Medical
ksm 24.08.27

Tracheostomy Tubes Market Growth & Trends:

The global tracheostomy tubes market size is expected to reach USD 136.7 million by 2030, registering a CAGR of 4.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is experiencing significant growth due to rising incidences of chronic respiratory diseases, technological advancements, and an increasing number of surgical procedures. An aging population further drives demand, as older individuals are more prone to respiratory conditions necessitating tracheostomies. For instance, according to National Center for Biotechnology Information (NCBI) data published in August 2022, Americans typically undergo about nine surgeries throughout their lives. Each year, over 51 million surgeries are performed in the U.S., with older adults comprising nearly half of the surgical patient population.

Enhanced healthcare infrastructure and favorable reimbursement policies are improving access to these procedures globally. Additionally, increased awareness and professional training in tracheostomy care are boosting adoption rates. Despite challenges such as high costs and potential complications, the market continues to expand, supported by ongoing innovations and improved patient outcomes.

Tracheostomy Tubes Market Report Highlights:

  • Based on the type, the cuffed segment accounted for the largest revenue share of 62.7% in 2023 and is expected to grow at the fastest CAGR of 4.3% during the forecast period, as it prevents aspiration and ensuring a secure airway by sealing the trachea with an inflatable cuff.
  • Based on the demographics, adult patients segment accounted for the largest revenue share of 71.8% in 2023 and is expected to grow at the fastest CAGR of 4.4% during the forecast period as they often require tracheostomy tubes for long-term airway management and to facilitate ventilation in cases of severe respiratory conditions.
  • Based on the end-use, the hospitals segment accounted for the largest revenue share of 49.4% in 2023 and is expected to grow at the fastest CAGR of 4.7% during the forecast period as it accounts for the majority of tracheostomy procedures and provides specialized care and management for patients requiring these devices.
  • In 2023, North America dominated with a share of 36.7% as this region is driven by advanced healthcare infrastructure, high prevalence of respiratory diseases, and significant healthcare expenditure.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1 Segment Definitions
    • 1.1.2. Type
    • 1.1.3. Demographics
    • 1.1.4. End Use
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecasts timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Demographics outlook
    • 2.2.3. End Use outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Tracheostomy Tubes Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing surgical procedures
      • 3.2.1.2. Rising prevalence of chronic respiratory diseases
      • 3.2.1.3. Awareness and education
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Complications and risks associated with tracheostomy
      • 3.2.2.2. Stringent regulatory requirements
  • 3.3. Tracheostomy Tubes Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Tracheostomy Tubes Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Tracheostomy Tubes Market: Type Movement Analysis
  • 4.3. Tracheostomy Tubes Market by Type Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Cuffed
    • 4.5.1. Cuffed Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Uncuffed
    • 4.6.1. Uncuffed Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Tracheostomy Tubes Market: Demographics Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Tracheostomy Tubes Market: Demographics Movement Analysis
  • 5.3. Tracheostomy Tubes Market by Demographics Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Adult Patients
    • 5.5.1. Adult Patients Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Pediatric/Neonatal Patients
    • 5.6.1. Pediatric/Neonatal Patients Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Tracheostomy Tubes Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Tracheostomy Tubes Market: End Use Movement Analysis
  • 6.3. Tracheostomy Tubes Market by End Use Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Hospitals
    • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Ambulatory Surgical Centers
    • 6.6.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Specialty Clinics
    • 6.7.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Tracheostomy Tubes Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Regional Tracheostomy Tubes Market movement analysis
  • 7.3. Tracheostomy Tubes Market: Regional Estimates & Trend Analysis by Technology & End Use
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5. North America
    • 7.5.1. North America Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement scenario
      • 7.5.2.5. U.S. Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement scenario
      • 7.5.3.5. Canada Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement scenario
      • 7.5.4.5. Mexico Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Europe
    • 7.5.6. Europe Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. UK
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Reimbursement scenario
      • 7.5.7.5. UK Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Germany
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Reimbursement scenario
      • 7.5.8.5. Germany Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. France
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Reimbursement scenario
      • 7.5.9.5. France Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.10. Italy
      • 7.5.10.1. Key Country Dynamics
      • 7.5.10.2. Competitive Scenario
      • 7.5.10.3. Regulatory Framework
      • 7.5.10.4. Reimbursement scenario
      • 7.5.10.5. Italy Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.11. Spain
      • 7.5.11.1. Key Country Dynamics
      • 7.5.11.2. Competitive Scenario
      • 7.5.11.3. Regulatory Framework
      • 7.5.11.4. Reimbursement scenario
      • 7.5.11.5. Spain Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.12. Denmark
      • 7.5.12.1. Key Country Dynamics
      • 7.5.12.2. Competitive Scenario
      • 7.5.12.3. Regulatory Framework
      • 7.5.12.4. Reimbursement scenario
      • 7.5.12.5. Denmark Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.13. Sweden
      • 7.5.13.1. Key Country Dynamics
      • 7.5.13.2. Competitive Scenario
      • 7.5.13.3. Regulatory Framework
      • 7.5.13.4. Reimbursement scenario
      • 7.5.13.5. Sweden Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.14. Norway
      • 7.5.14.1. Key Country Dynamics
      • 7.5.14.2. Competitive Scenario
      • 7.5.14.3. Regulatory Framework
      • 7.5.14.4. Reimbursement scenario
      • 7.5.14.5. Norway Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. Japan Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. China Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement scenario
      • 7.6.4.5. India Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement scenario
      • 7.6.5.5. South Korea Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement scenario
      • 7.6.6.5. Australia Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement scenario
      • 7.6.7.5. Thailand Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. Brazil Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. Argentina Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Middle East & Africa
    • 7.8.1. Middle East & Africa Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement scenario
      • 7.8.2.5. South Africa Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement scenario
      • 7.8.3.5. Saudi Arabia Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Reimbursement scenario
      • 7.8.4.5. UAE Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Reimbursement scenario
      • 7.8.5.5. Kuwait Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. Pulmodyne, Inc.
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Smiths Group plc
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Medtronic
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. TRACOE Medical GmbH
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Teleflex, Inc.
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. TuoRen
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. ConvaTec Group
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Boston Medical
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Fisher & Paykel Healthcare Ltd.
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Angioplast
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives
    • 8.2.11. ICU Medical
      • 8.2.11.1. Company overview
      • 8.2.11.2. Financial performance
      • 8.2.11.3. Product benchmarking
      • 8.2.11.4. Strategic initiatives
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦